The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Senexon-S
Docusate Sodium 50mg and Sennosides 8.6mg · SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1 · Tablet, Film Coated · Oral · NCS HealthCare of KY, LLC dba Vangard Labs
NDC 00615-8331-05 · 15 TABLET, FILM COATED in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for docusate sodium 50 mg and sennosides 8.6 mg (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- 505G(a)(3)
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Docusate Sodium 50mg and Sennosides 8.6mg (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| NCS HealthCare of KY, LLC dba Vangard Labs | SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Rugby Laboratories | SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| NCS HealthCare of KY, LLC dba Vangard Labs | SENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Rugby Laboratories | SENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| NCS HealthCare of KY, LLC dba Vangard Labs | DOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Rugby Laboratories | DOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Senexon-S — NDC 00615-8331-05," retrieved September 3, 2026, https://drugdashboards.com/drug/00615833105.
Free to cite with attribution — see how the data is put together.